{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:44:42Z","timestamp":1787161482024,"version":"build-2736575974"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.2169\/internalmedicine.8104-21","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T17:13:16Z","timestamp":1636737196000},"page":"1785-1788","source":"Crossref","is-referenced-by-count":5,"title":["The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient"],"prefix":"10.2169","volume":"61","author":[{"given":"Hiroki","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"},{"name":"Department of Rheumatology, Medical Corporation JR Hiroshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Komoshita","sequence":"additional","affiliation":[{"name":"Postgraduate Clinical Training Center, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumichi","family":"Suma","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"},{"name":"Department of Rheumatology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"},{"name":"Department of Rheumatology, Hiroshima Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hiroshima University Hospital, Japan"},{"name":"Department of Dermatology, Hiroshima Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Mokuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"},{"name":"Department of Rheumatology, Medical Corporation JR Hiroshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cohen JI. Clinical practice: herpes zoster. N Engl J Med 369: 255-263, 2013.","DOI":"10.1056\/NEJMcp1302674"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection 42: 325-334, 2014.","DOI":"10.1007\/s15010-013-0550-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Osborn LP, Cohen PR. Non-dermatomal varicella-zoster skin infection: disseminated cutaneous herpes zoster without dermatome in an immunosuppressed woman. Dermatol Online J 23: 13030\/qt36j330n5, 2017.","DOI":"10.5070\/D32310036993"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ueno H, Hayashi M, Nagumo S, et al. Disseminated varicella-zoster virus infection causing fatal pneumonia in an immunocompromised patient with chronic interstitial pneumonia. Intern Med 60: 1077-1082, 2021.","DOI":"10.2169\/internalmedicine.5396-20"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol 41: 1-14, 1999.","DOI":"10.1016\/S0190-9622(99)70398-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mirouse A, Vignon P, Piron P, et al. Severe varicella-zoster virus pneumonia: a multicenter cohort study. Crit Care 21: 137, 2017.","DOI":"10.1186\/s13054-017-1731-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tsuji H, Yoshifuji H, Fujii T, et al. Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. Mod Rheumatol 27: 155-161, 2017.","DOI":"10.3109\/14397595.2014.948981"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kusawake T, Kowalski D, Takada A, et al. The influence of hepatic and renal impairment on the pharmacokinetics of a treatment for herpes zoster, amenamevir (ASP2151): phase 1, open-label, single-dose, parallel-group studies. Adv Ther 34: 2612-2624, 2017.","DOI":"10.1007\/s12325-017-0643-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Taga S, Nakamura S, Makita M, Nishiyama O. Adult primary varicella pneumonia: high-resolution computed tomography findings. Intern Med 53: 331-332, 2014.","DOI":"10.2169\/internalmedicine.53.1521"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kim JS, Ryu CW, Lee SI, Sung DW, Park CK. High-resolution CT findings of varicella-zoster pneumonia. Am J Roentgenol 172: 113-116, 1999.","DOI":"10.2214\/ajr.172.1.9888749"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Buchan SA, Daneman N, Wang J, et al. Incidence of hospitalizations and emergency department visits for herpes zoster in immunocompromised and immunocompetent adults in Ontario, Canada, 2002-2016. Clin Infect Dis 71: 22-29, 2020.","DOI":"10.1093\/cid\/ciz769"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Revankar SG, Applegate AL, Markovitz DM. Delirium associated with acyclovir treatment in a patient with renal failure. Clin Infect Dis 21: 435-436, 1995.","DOI":"10.1093\/clinids\/21.2.435"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ryan L, Heed A, Foster J, Valappil M, Schmid ML, Duncan CJA. Acute kidney injury (AKI) associated with intravenous aciclovir in adults: incidence and risk factors in clinical practice. Int J Infect Dis 74: 97-99, 2018.","DOI":"10.1016\/j.ijid.2018.07.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tsuruoka S, Endo T, Seo M, Hashimoto N. Pharmacokinetics and dialyzability of a single oral dose of amenamevir, an anti-herpes drug, in hemodialysis patients. Adv Ther 37: 3234-3245, 2020.","DOI":"10.1007\/s12325-020-01375-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kawashima M, Nemoto O, Honda M, et al. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: a randomized, double-blind, valaciclovir-controlled phase 3 study. J Dermatol 44: 1219-1227, 2017.","DOI":"10.1111\/1346-8138.13948"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ishiguro A, Takama H, Yanagishita T, Ohshima Y, Watanabe D. Efficacy of amenamevir for the treatment of herpes zoster in an immunocompromised patient: report of a case. J Dermatol 46: e270-e271, 2019.","DOI":"10.1111\/1346-8138.14854"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shoji H, Fukushima Y, Sakoda Y, Abe T, Oguri S, Baba M. Varicella-zoster virus-associated polyradiculoneuritis with concomitant herpes zoster eruption: a case report. Rinsho Shinkeigaku (Clin Neurol) 59: 641-645, 2019 (in Japanese).","DOI":"10.5692\/clinicalneurol.cn-001302"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kubota M, Haruta T. The role of serum KL-6 measurement in common pediatric respiratory infections. J Infect Chemother 12: 22-24, 2006.","DOI":"10.1007\/s10156-005-0416-9"},{"key":"19","unstructured":"19. Nakajima H, Harigai M, Hara M, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 27: 1164-1170, 2000."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/11\/61_8104-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:14:02Z","timestamp":1715217242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/11\/61_8104-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8104-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"8104-21"}}